# A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers

> clinical trial · VERIFIED · 2026-06-10

Status: COMPLETED · Sponsor: ModernaTX, Inc. · Condition: Respiratory Syncytial Virus

- Company: ModernaTX, Inc.
- Sector: vaccine
- Primary source: https://clinicaltrials.gov/study/NCT06143046

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.